Gabapentin Capsule
Product Images NDC 16714-663

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16714-663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation Of Cockcroft And Gault (Gabapentin Fig1)

This text appears to be a formula for calculating something with a person's age and weight, followed by a calculation involving creatinine levels, specifically mentioning values for female patients. The specific purpose or context is not provided, so it is not possible to determine what exactly is being calculated or why.*

FDA Label Image

Fig-2 (Gabapentin Fig2)

The text appears to be a table with some headings and values related to pain scores and doses of medication (placebo and gabapentin). Without further context, it is difficult to provide a specific description or interpretation.*

FDA Label Image

Fig-3 (Gabapentin Fig3)

This appears to be a table showing the mean pain scores for different treatments (placebo, Gatspntin 1600y, Gaagentn 2400sy) at different time periods (Baseline, Week 1, Week 2, Week 3, Week 4). Not much context is provided, so it's difficult to determine what type of pain or condition is being studied.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Capsules Bottle))

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))

This is a medication guide for NDG 16714-662-01 Gabapentin Capsules of 300mg. It contains 100 capsules and the usual dosage is as mentioned in the package insert. The medication should be kept out reach of children and stored at appropriate temperatures. The manufacturer of this medication is Aurobindo Pharma Limited and it is distributed by Northstar Rx LLC. Contact details for medication guides are available at their website or by calling their helpline number.*

FDA Label Image

Package Label-principal Display Panel (400 mg (100 Capsules Bottle))

This is a description of a medication called Gabapentin Capsules, USP, which come in a presentation of 100 capsules of 400mg, and it should be kept away from children at a temperature between 20°C to 25°C. It was manufactured by Aurobindo Pharma Limited and distributed by Northstar Rx LLC. It is highly recommended that patients read the Medication Guide provided separately by the pharmacist before use, and for more information to visit www.northstarind.com/products or call 1-800-206-7821.*

FDA Label Image

Chemical Structure (Gabapentin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.